Tenofovir/emtricitabine/efavirenz

DRUG2 trials

Sponsors

Indiana University, Mahidol University

Conditions

Anti-Retroviral AgentsDyslipidemiasEfavirenzHIVHIV-1-infectionRilpivirineSustained Virologic Response

Phase 4

Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients

CompletedNCT01270802

Indiana UniversityHIV

Start: 2011-04-30End: 2013-04-30Updated: 2013-12-18

Unknown Phase

Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression

CompletedNCT03251690

Mahidol UniversityAnti-Retroviral Agents, Dyslipidemias, Efavirenz +3

Start: 2016-10-27End: 2018-04-30Updated: 2019-05-07